Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- Manual Ventilation Efficacy With MVG Device: Complete Statistical AnalysisIndependent statistical analysis of Manual Ventilation Efficacy With MVG Device: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05059366).
- MAP-PAFIndependent statistical analysis of Ablation of the Pulmonary Veins for Paroxysmal Afib: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00744874).
- MAP-XIndependent statistical analysis of Study Using Xolair in Rush Multi Oral Immunotherapy in Multi Food Allergic Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- MAP4BUPIndependent statistical analysis of Mobile Medication Adherence Platform for Buprenorphine-Naloxone During Treatment of Opioid Use Disorder: Phase I Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- MAPLEIndependent statistical analysis of Myopia Assessment of Two Manufacturing Processes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04126057).
- MAPP-IIIndependent statistical analysis of Developing a Positive Psychology Intervention to Promote Health Behaviors in Metabolic Syndrome: Proof-of Concept Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery: Complete Statistical AnalysisIndependent statistical analysis of Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- MAPSIndependent statistical analysis of MRI-Mapped Dose-Escalated Salvage Radiotherapy Post-Prostatectomy: The MAPS Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01411345).
- Maraviroc as GVHD Prophylaxis in Transplant Recipients: Complete Statistical AnalysisIndependent statistical analysis of Maraviroc as GVHD Prophylaxis in Transplant Recipients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02167451).
- Maraviroc in Patients Undergoing Non-Myeloablative Allogeneic Stem-Cell Transplantation: Complete Statistical AnalysisIndependent statistical analysis of Maraviroc in Patients Undergoing Non-Myeloablative Allogeneic Stem-Cell Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00948753).
- MaRCH-onIndependent statistical analysis of Imaging Biomarkers in Crohn's Associated Spondyloarthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02709694).
- Maribavir Versus Oral Ganciclovir For The Prevention of Cytomegalovirus (CMV) Disease in Liver Transplant Recipients: Complete Statistical AnalysisIndependent statistical analysis of Maribavir Versus Oral Ganciclovir For The Prevention of Cytomegalovirus (CMV) Disease in Liver Transplant Recipients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Maribavir vs. Valganciclovir for CMV Prophylaxis in High-Risk Kidney Transplant Recipients: Complete Statistical AnalysisIndependent statistical analysis of Maribavir vs. Valganciclovir for CMV Prophylaxis in High-Risk Kidney Transplant Recipients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Marijuana in Combination With Opioids in Palliative and Hospice Patients: Complete Statistical AnalysisIndependent statistical analysis of Marijuana in Combination With Opioids in Palliative and Hospice Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03233633).
- MARINAIndependent statistical analysis of Study of AOC 1001 in Adult Myotonic Dystrophy Type 1 (DM1) Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- MARINOLIndependent statistical analysis of Dronabinol Treatment for Marijuana Addiction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00217971).
- MARLINA – T2D : Efficacy, Safety & Modification of Albuminuria in Type 2 Diabetes Subjects With Renal Disease With LINAgliptin: Complete Statistical AnalysisIndependent statistical analysis of MARLINA - T2D : Efficacy, Safety & Modification of Albuminuria in Type 2 Diabetes Subjects With Renal Disease With LINAgliptin: primary endpoint results, effect estimate with confidence interval,…
- MARRSIndependent statistical analysis of Millipede AspiRation for Revascularization in Stroke (MARRS) Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05714501).
- MARSIndependent statistical analysis of Microvascular Flow Assessment Repeatability Study: The MARS Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01242020).
- MARSIndependent statistical analysis of Project MARS: Mobile-Assistance for Regulating Smoking: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04376489).
- Mars Flavanol Exercise and Cognitive Function Study: Complete Statistical AnalysisIndependent statistical analysis of Mars Flavanol Exercise and Cognitive Function Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01180127).
- MARS GIIndependent statistical analysis of Safety and Feasibility of the Use of the Dual Robotic Arm Accessory With the Levita Magnetic Surgical System in Laparoscopic Procedures: primary endpoint results, effect estimate with confidence…
- MARVEL1Independent statistical analysis of A Fabry Disease Gene Therapy Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04040049).
- MASCIndependent statistical analysis of MASC: Reducing Stress for Caregivers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05847153).
- MASCIIndependent statistical analysis of Allogeneic SCT Of Pts With SCID And Other Primary Immunodeficiency Disorders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- MASHIndependent statistical analysis of Manual Therapy and Strengthening for the Hip in Older Adults With Chronic Low Back Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- MASHIndependent statistical analysis of Memory Training in Aneurysmal Subarachnoid Hemorrhage Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02864940).
- Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-MD1003 in Healthy Male Subjects: Complete Statistical AnalysisIndependent statistical analysis of Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-MD1003 in Healthy Male Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Mass-balance Study of [14C]-APD421 in Healthy Volunteers: Complete Statistical AnalysisIndependent statistical analysis of Mass-balance Study of [14C]-APD421 in Healthy Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02881840).
- MASS2Independent statistical analysis of Micra Accelerometer Sensor Study 2: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02930980).
- Massive Iron Deposit Assessment: Complete Statistical AnalysisIndependent statistical analysis of Massive Iron Deposit Assessment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01572922).
- Massive Pulmonary Embolism: Trial of Non-immunogenic Recombinant Staphylokinase VS Alteplase FORPE: Complete Statistical AnalysisIndependent statistical analysis of Massive Pulmonary Embolism: Trial of Non-immunogenic Recombinant Staphylokinase VS Alteplase FORPE: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- MASTIndependent statistical analysis of MAST Trial: Multi-modal Analgesic Strategies in Trauma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03472469).
- MASTIndependent statistical analysis of Study of the Mechanisms of Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00595153).
- Mast Cell Activation Test in Allergic Disease: Complete Statistical AnalysisIndependent statistical analysis of Mast Cell Activation Test in Allergic Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03406325).
- Mastectomy Flap Temperature Study: Complete Statistical AnalysisIndependent statistical analysis of Mastectomy Flap Temperature Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05395936).
- Master Study for the Investigation of Safety and Efficacy of the EVIA Pacemaker: Complete Statistical AnalysisIndependent statistical analysis of Master Study for the Investigation of Safety and Efficacy of the EVIA Pacemaker: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- MasterKey-01Independent statistical analysis of A Study of BDTX-189, an Orally Available Allosteric ErbB Inhibitor, in Patients With Advanced Solid Tumors.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- MASTERKEY-265Independent statistical analysis of Pembrolizumab With Talimogene Laherparepvec or Placebo in Unresected Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02263508).
- MASTERSIndependent statistical analysis of Maintaining Suppression of Testosterone With Transdermal Estradiol Gel: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02349386).
- MASTERYIndependent statistical analysis of Text Messaging to Increase Activity in Midlife: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04849052).
- MATADORSIndependent statistical analysis of Managing AsThma AnD Obesity Related Symptoms (MATADORS) Feasibility Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05742646).
- MATCh-GDMIndependent statistical analysis of Metabolic Analysis for Treatment Choice in Gestational Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03029702).
- MATERIndependent statistical analysis of A Study of Metronidazole Cream in the Prevention and Treatment of Tarceva (Erlotinib)-Associated Rash: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Maternal Metabolic and Molecular Changes Induced by Preconception Weight Loss and Their Effects on Birth Outcomes: Complete Statistical AnalysisIndependent statistical analysis of Maternal Metabolic and Molecular Changes Induced by Preconception Weight Loss and Their Effects on Birth Outcomes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Maternal Role in Oral Feed Establishment in Preterm Neonates: Complete Statistical AnalysisIndependent statistical analysis of Maternal Role in Oral Feed Establishment in Preterm Neonates: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05484726).
- MATOCSSIndependent statistical analysis of Mepolizumab As a Steroid-sparing Treatment Option in the Churg Strauss Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- MATRIX-2Independent statistical analysis of Phase 3 Study of Efficacy and Safety of the XaraColl® Bupivacaine Implant After Hernioplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Mature B-Cell Lymphoma And Leukemia Study III: Complete Statistical AnalysisIndependent statistical analysis of Mature B-Cell Lymphoma And Leukemia Study III: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01046825).
- MAVANIndependent statistical analysis of Maternal Adversity, Vulnerability and Neurodevelopment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03434457).